167 related articles for article (PubMed ID: 36918802)
21. High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration.
Li H; Su Q; Li B; Lan L; Wang C; Li W; Wang G; Chen W; He Y; Zhang C
J Cell Mol Med; 2020 Apr; 24(8):4452-4465. PubMed ID: 32176425
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of long non-coding RNA DQ786243 promotes the progression of gastric cancer.
Shan T; Fan J; Zhao Q; Deng K; Xia J
Mol Med Rep; 2017 Oct; 16(4):3761-3768. PubMed ID: 28731138
[TBL] [Abstract][Full Text] [Related]
23. [CircPCSK5 is highly expressed in gastric cancer and promotes cancer cell proliferation, invasion and epithelial-mesenchymal transition].
Zuo X; Cai J; Chen Z; Li Y; Zhang D
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1440-1451. PubMed ID: 36329577
[TBL] [Abstract][Full Text] [Related]
24. Targeting kinesin family member 21B by miR-132-3p represses cell proliferation, migration and invasion in gastric cancer.
Liu B; Qiang L; Guan B; Ji Z
Bioengineered; 2022 Apr; 13(4):9006-9018. PubMed ID: 35341446
[TBL] [Abstract][Full Text] [Related]
25. PDK4 Constitutes a Novel Prognostic Biomarker and Therapeutic Target in Gastric Cancer.
Zhang Z; Han S; Ouyang S; Zeng Z; Liu Z; Sun J; Kang W
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626257
[TBL] [Abstract][Full Text] [Related]
26. EDIL3 is a potential prognostic biomarker that correlates with immune infiltrates in gastric cancer.
Ke B; Liang ZK; Li B; Wang XJ; Liu N; Liang H; Zhang RP
PeerJ; 2023; 11():e15559. PubMed ID: 37576496
[TBL] [Abstract][Full Text] [Related]
27. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
[TBL] [Abstract][Full Text] [Related]
28. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
Li J; Zou X
Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
[TBL] [Abstract][Full Text] [Related]
29. COLEC12 Promotes Tumor Progression and Is Correlated With Poor Prognosis in Gastric Cancer.
Sun X; Zhang Q; Shu P; Lin X; Gao X; Shen K
Technol Cancer Res Treat; 2023; 22():15330338231218163. PubMed ID: 38112409
[TBL] [Abstract][Full Text] [Related]
30. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway.
Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of the expression of SLC30A family genes and prognosis in human gastric cancer.
Guo Y; He Y
Sci Rep; 2020 Oct; 10(1):18352. PubMed ID: 33110097
[TBL] [Abstract][Full Text] [Related]
32. Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells.
Liu H; Xu J; Yao Q; Zhang Z; Guo Q; Lin J
Med Sci Monit; 2020 Jun; 26():e922217. PubMed ID: 32591494
[TBL] [Abstract][Full Text] [Related]
33. Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer.
Li L; Huang S; Yao Y; Chen J; Li J; Xiang X; Deng J; Xiong J
World J Surg Oncol; 2020 Dec; 18(1):324. PubMed ID: 33292276
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer.
Morotti M; Zois CE; El-Ansari R; Craze ML; Rakha EA; Fan SJ; Valli A; Haider S; Goberdhan DCI; Green AR; Harris AL
Br J Cancer; 2021 Jan; 124(2):494-505. PubMed ID: 33028955
[TBL] [Abstract][Full Text] [Related]
35. M2 macrophage-derived extracellular vesicles promote gastric cancer progression via a microRNA-130b-3p/MLL3/GRHL2 signaling cascade.
Zhang Y; Meng W; Yue P; Li X
J Exp Clin Cancer Res; 2020 Jul; 39(1):134. PubMed ID: 32660626
[TBL] [Abstract][Full Text] [Related]
36. A comprehensive analysis of potential gastric cancer prognostic biomarker ITGBL1 associated with immune infiltration and epithelial-mesenchymal transition.
Wang Z; Fu L; Zhang J; Ge Y; Guo C; Wang R; Deng M; Wang Q; Wang Z
Biomed Eng Online; 2022 May; 21(1):30. PubMed ID: 35596183
[TBL] [Abstract][Full Text] [Related]
37. SLC38A2 Overexpression Induces a Cancer-like Metabolic Profile and Cooperates with SLC1A5 in Pan-cancer Prognosis.
Huang MS; Chang JH; Lin WC; Cheng YH; Li FA; Suen CS; Hwang MJ; Chang CK; Mou KY
Chem Asian J; 2020 Nov; 15(22):3861-3872. PubMed ID: 32996252
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive Analysis of Immune Implications and Prognostic Value of SPI1 in Gastric Cancer.
Huang J; Chen W; Jie Z; Jiang M
Front Oncol; 2022; 12():820568. PubMed ID: 35237521
[TBL] [Abstract][Full Text] [Related]
39. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression.
Pan L; Liang W; Fu M; Huang ZH; Li X; Zhang W; Zhang P; Qian H; Jiang PC; Xu WR; Zhang X
J Cancer Res Clin Oncol; 2017 Jun; 143(6):991-1004. PubMed ID: 28285404
[TBL] [Abstract][Full Text] [Related]
40. Fibrinogen‑like‑protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.
Zhang Y; Qiao HX; Zhou YT; Hong L; Chen JH
Mol Med Rep; 2018 Aug; 18(2):1465-1472. PubMed ID: 29845203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
